1. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2019. CA: a cancer journal for clinicians 2019, 69(1):7-34.
2. Weigelt B, Peterse JL, van 't Veer LJ: Breast cancer metastasis: markers and models. Nature reviews Cancer 2005, 5(8):591-602.
3. Tong CWS, Wu M, Cho WCS, To KKW: Recent Advances in the Treatment of Breast Cancer. Frontiers in oncology 2018, 8:227.
4. Yoon H, Dehart JP, Murphy JM, Lim ST: Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2015, 63(2):114-128.
5. Golubovskaya VM, Cance WG: FAK and p53 protein interactions. Anti-cancer agents in medicinal chemistry 2011, 11(7):617-619.
6. Shtam T, Naryzhny S, Samsonov R, Karasik D, Mizgirev I, Kopylov A, Petrenko E, Zabrodskaya Y, Kamyshinsky R, Nikitin D et al: Plasma exosomes stimulate breast cancer metastasis through surface interactions and activation of FAK signaling. Breast cancer research and treatment 2019, 174(1):129-141.
7. Tancioni I, Miller NL, Uryu S, Lawson C, Jean C, Chen XL, Kleinschmidt EG, Schlaepfer DD: FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth. Breast cancer research : BCR 2015, 17:47.
8. Golubovskaya VM, Ylagan L, Miller A, Hughes M, Wilson J, Wang D, Brese E, Bshara W, Edge S, Morrison C et al: High focal adhesion kinase expression in breast carcinoma is associated with lymphovascular invasion and triple-negative phenotype. BMC cancer 2014, 14:769.
9. Lee BY, Timpson P, Horvath LG, Daly RJ: FAK signaling in human cancer as a target for therapeutics. Pharmacology & therapeutics 2015, 146:132-149.
10. Lv PC, Jiang AQ, Zhang WM, Zhu HL: FAK inhibitors in Cancer, a patent review. Expert opinion on therapeutic patents 2018, 28(2):139-145.
11. Sulzmaier FJ, Jean C, Schlaepfer DD: FAK in cancer: mechanistic findings and clinical applications. Nature reviews Cancer 2014, 14(9):598-610.
12. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC: The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nature reviews Cancer 2005, 5(7):505-515.
13. Stokes JB, Adair SJ, Slack-Davis JK, Walters DM, Tilghman RW, Hershey ED, Lowrey B, Thomas KS, Bouton AH, Hwang RF et al: Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment. Molecular cancer therapeutics 2011, 10(11):2135-2145.
14. Roberts WG, Ung E, Whalen P, Cooper B, Hulford C, Autry C, Richter D, Emerson E, Lin J, Kath J et al: Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer research 2008, 68(6):1935-1944.
15. Green AR, Caracappa D, Benhasouna AA, Alshareeda A, Nolan CC, Macmillan RD, Madhusudan S, Ellis IO, Rakha EA: Biological and clinical significance of PARP1 protein expression in breast cancer. Breast cancer research and treatment 2015, 149(2):353-362.
16. Schultze A, Fiedler W: Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer. Expert opinion on investigational drugs 2010, 19(6):777-788.
17. Milas L, Peters LJ, Ito H: Spontaneous metastasis: random or selective? Clinical & experimental metastasis 1983, 1(4):309-315.
18. Fabbro D, Ruetz S, Buchdunger E, Cowan-Jacob SW, Fendrich G, Liebetanz J, Mestan J, O'Reilly T, Traxler P, Chaudhuri B et al: Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacology & therapeutics 2002, 93(2-3):79-98.
19. Zwick E, Bange J, Ullrich A: Receptor tyrosine kinases as targets for anticancer drugs. Trends in molecular medicine 2002, 8(1):17-23.
20. Bennasroune A, Gardin A, Aunis D, Cremel G, Hubert P: Tyrosine kinase receptors as attractive targets of cancer therapy. Critical reviews in oncology/hematology 2004, 50(1):23-38.
21. Liu CY, Chu PY, Huang CT, Chen JL, Yang HP, Wang WL, Lau KY, Lee CH, Lan TY, Huang TT et al: Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells. Cancers 2019, 11(1).
22. Luo M, Guan JL: Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer letters 2010, 289(2):127-139.